MX387217B - Composiciones de solución sólida para aines. - Google Patents

Composiciones de solución sólida para aines.

Info

Publication number
MX387217B
MX387217B MX2018001584A MX2018001584A MX387217B MX 387217 B MX387217 B MX 387217B MX 2018001584 A MX2018001584 A MX 2018001584A MX 2018001584 A MX2018001584 A MX 2018001584A MX 387217 B MX387217 B MX 387217B
Authority
MX
Mexico
Prior art keywords
temperature
weight
nsaids
solid solution
liquid
Prior art date
Application number
MX2018001584A
Other languages
English (en)
Spanish (es)
Other versions
MX2018001584A (es
Inventor
John Brew
Richard Robert Reiley
Robin Mark Bannister
Wilson Caparros-Wanderley
Original Assignee
Infirst Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/821,687 external-priority patent/US9744132B2/en
Priority claimed from EP15180256.8A external-priority patent/EP3127556A1/en
Application filed by Infirst Healthcare Ltd filed Critical Infirst Healthcare Ltd
Publication of MX2018001584A publication Critical patent/MX2018001584A/es
Publication of MX387217B publication Critical patent/MX387217B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2018001584A 2015-08-07 2016-08-08 Composiciones de solución sólida para aines. MX387217B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/821,687 US9744132B2 (en) 2010-10-29 2015-08-07 Solid solution compositions and use in chronic inflammation
EP15180256.8A EP3127556A1 (en) 2015-08-07 2015-08-07 Solid solution compositions for nsaid
PCT/EP2016/068900 WO2017025517A1 (en) 2015-08-07 2016-08-08 SOLID SOLUTION COMPOSITIONS FOR NSAIDs

Publications (2)

Publication Number Publication Date
MX2018001584A MX2018001584A (es) 2019-01-31
MX387217B true MX387217B (es) 2025-03-18

Family

ID=56800263

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001584A MX387217B (es) 2015-08-07 2016-08-08 Composiciones de solución sólida para aines.

Country Status (10)

Country Link
EP (2) EP3331568B1 (https=)
JP (1) JP6989489B2 (https=)
CN (1) CN108025078A (https=)
AU (1) AU2016306610B2 (https=)
CA (1) CA2994899C (https=)
ES (2) ES2906571T3 (https=)
IL (1) IL257385A (https=)
MX (1) MX387217B (https=)
PL (1) PL3331568T3 (https=)
WO (1) WO2017025517A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
EP4312978A2 (en) 2021-03-27 2024-02-07 TRX Biosciences Limited Compositions having improved bioavailability of therapeutics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US9308213B2 (en) * 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695432B2 (en) * 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
ES2763352T3 (es) * 2013-01-14 2020-05-28 Infirst Healthcare Ltd Composiciones de solución sólida y uso en inflamación crónica

Also Published As

Publication number Publication date
EP3988091B1 (en) 2025-10-01
AU2016306610B2 (en) 2019-02-28
EP3988091A1 (en) 2022-04-27
ES3057447T3 (en) 2026-03-02
ES2906571T3 (es) 2022-04-19
JP6989489B2 (ja) 2022-01-05
CN108025078A (zh) 2018-05-11
EP3988091C0 (en) 2025-10-01
AU2016306610A1 (en) 2018-03-01
MX2018001584A (es) 2019-01-31
IL257385A (en) 2018-04-30
JP2018526351A (ja) 2018-09-13
PL3331568T3 (pl) 2022-02-28
CA2994899A1 (en) 2017-02-16
WO2017025517A1 (en) 2017-02-16
EP3331568A1 (en) 2018-06-13
CA2994899C (en) 2024-04-16
EP3331568B1 (en) 2021-12-15

Similar Documents

Publication Publication Date Title
MX387217B (es) Composiciones de solución sólida para aines.
CL2017002939A1 (es) Composiciones farmacéuticas tópicas
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
CO6710926A2 (es) Compuestos de n-heteroarilo
BR112018010234A2 (pt) spray formador de película tópica
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
BR112016027435A2 (pt) formulação inovadora de meloxicam
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
BR112015017251A8 (pt) composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
CL2022002566A1 (es) Combinaciones de brimonidina de dosis baja y usos de las mismas. (solicitud divisional de 201903572)
AR106364A1 (es) Derivados de insulina y sus usos médicos
MX381776B (es) Formulacion acuosa que comprende paracetamol e ibuprofeno.
CL2017001913A1 (es) Composición tópica curativa
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
MX379253B (es) Formulaciones de oximetazolina estabilizadas y sus usos.
AR101901A1 (es) Tratamiento de enfermedades neurodegenerativas con una combinación de laquinimod y fingolimod
CO2021004612A2 (es) Derivados de 4 pirazin 2 ilmetil-morfolina y su uso como medicamento
CU24440B1 (es) Composición farmacéutica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
PE20171340A1 (es) Composicion farmaceutica para el tratamiento de enfermedades gastrointestinales
ES2422563A1 (es) Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma
UA120075C2 (uk) Фармацевтична композиція для лікування запальних змін прямої кишки
MX382521B (es) Nuevos compuestos bioaromaticos de propinilo, composiciones farmaceuticas y cosmeticas que contienen los mismos y usos de los mismos.
UY37426A (es) Método para producir una composición farmacéuticamente estable presentada como una solución acuosa